Summary

The global Burns and Scalds Treatment market is projected to grow from US$ 2498 million in 2025 to US$ 3237 million by 2032, at a CAGR of 3.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
In 2025, the global production volume of Burns and Scalds Treatment products reached approximately 135 million units, with an average selling price of USD 18.5 per unit, production capacity of approximately 185 million units, and a gross margin of 42%.
Burns and Scalds Treatment refers to therapeutic products and related wound-care products used for skin and soft-tissue thermal injuries caused by flames, hot liquids, steam, contact with hot objects, and other heat sources. Major products include burn ointments and creams, gels, sprays, and burn wound dressings. These products are primarily used to protect wounds, maintain an appropriate wound-healing environment, relieve local discomfort, and support wound repair. Depending on the depth and severity of the burn, they are used across home first aid, outpatient clinics, hospitals, and specialized burn care settings.
The Burns and Scalds Treatment market is mainly driven by demand arising from household accidents, industrial accidents, kitchen and food-service scalds, fires, and other thermal injuries. The product mix is gradually expanding from traditional burn ointments, creams, and basic dressings toward advanced wound-care products such as hydrogels, foam dressings, and antimicrobial dressings. Hospitals place greater emphasis on infection control, wound-healing performance, and ease of dressing changes, while the home-care market focuses more on convenience and immediate first-aid treatment. With continued advances in wound-care technologies and improved burn wound management in healthcare institutions, the penetration of higher-value advanced dressings and professional burn-care products is expected to increase further.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Burns and Scalds Treatment market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
MEBO
B. Braun
Integra LifeSciences
Tianjin Pharmaceutical Da Ren Tang Group Corporation
Smith & Nephew
Yangtze River Pharmaceutical
STADA Thornton & Ross
Kenvue Brands LLC
Changchun OVERSEAS
Orkla Health
Guangdong Hengjian Investment
Otsuka Pharmaceutical Co
Tonghua Maoxiang Medical Co
Cipla
Mitsubishi Tanabe Pharma Corporation
Chongqing GankyilL Bio-Technology
Quest Products, LLC
Jianmin Pharmaceutical Group Co
Acme United Corp.
Dongwha Pharm
CR Pharmaceutical Commercial Group Co
Safetec Of America
Chongqing Taiji Industry
North China Pharmaceutical Co
Xiangxi Hongcheng
Aoxing Pharmaceutical
Jilin Aodong Pharmaceutical Group Co
Beijing Tong Ren Tang Chinese Medicine Co
Segment by Type
Salve
Spray
Oil
Other
Segment by Treatment Product Type
Burn Ointments and Creams
Burn Dressings
Burn Sprays and Gels
Others
Segment by Burn Depth
Superficial Burns (First-degree)
Superficial Partial-thickness Burns (Superficial Second-degree)
Deep Partial-thickness Burns (Deep Second-degree)
Full-thickness Burns (Third-degree)
Segment by Application
Hospitals and Clinics
Retail Pharmacies
E-commerce Platforms
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Burns and Scalds Treatment study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Burns and Scalds Treatment: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Burns and Scalds Treatment Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Salve
1.2.3 Spray
1.2.4 Oil
1.2.5 Other
1.3 Market Segmentation by Treatment Product Type
1.3.1 Global Burns and Scalds Treatment Market Size by Treatment Product Type, 2021 vs 2025 vs 2032
1.3.2 Burn Ointments and Creams
1.3.3 Burn Dressings
1.3.4 Burn Sprays and Gels
1.3.5 Others
1.4 Market Segmentation by Burn Depth
1.4.1 Global Burns and Scalds Treatment Market Size by Burn Depth, 2021 vs 2025 vs 2032
1.4.2 Superficial Burns (First-degree)
1.4.3 Superficial Partial-thickness Burns (Superficial Second-degree)
1.4.4 Deep Partial-thickness Burns (Deep Second-degree)
1.4.5 Full-thickness Burns (Third-degree)
1.5 Market Segmentation by Application
1.5.1 Global Burns and Scalds Treatment Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Hospitals and Clinics
1.5.3 Retail Pharmacies
1.5.4 E-commerce Platforms
1.5.5 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Burns and Scalds Treatment Revenue Estimates and Forecasts (2021-2032)
2.2 Global Burns and Scalds Treatment Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Burns and Scalds Treatment Sales Estimates and Forecasts (2021-2032)
2.4 Global Burns and Scalds Treatment Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Burns and Scalds Treatment Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Burns and Scalds Treatment Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Salve: Market Share by Key Manufacturers
3.5.2 Spray: Market Share by Key Manufacturers
3.5.3 Oil: Market Share by Key Manufacturers
3.5.4 Other: Market Share by Key Manufacturers
3.6 Global Burns and Scalds Treatment Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Burns and Scalds Treatment Sales Performance by Type
4.1.1 Global Burns and Scalds Treatment Sales Volume by Type (2021-2032)
4.1.2 Global Burns and Scalds Treatment Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Burns and Scalds Treatment Sales Performance by Treatment Product Type
4.2.1 Global Burns and Scalds Treatment Sales Volume by Treatment Product Type (2021-2032)
4.2.2 Global Burns and Scalds Treatment Revenue by Treatment Product Type (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Treatment Product Type (2021-2032)
4.3 Global Burns and Scalds Treatment Sales Performance by Burn Depth
4.3.1 Global Burns and Scalds Treatment Sales Volume by Burn Depth (2021-2032)
4.3.2 Global Burns and Scalds Treatment Revenue by Burn Depth (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Burn Depth (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Burns and Scalds Treatment Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Burns and Scalds Treatment Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Burns and Scalds Treatment Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Burns and Scalds Treatment Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Burns and Scalds Treatment Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Burns and Scalds Treatment Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Burns and Scalds Treatment Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Burns and Scalds Treatment Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Burns and Scalds Treatment Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Burns and Scalds Treatment Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Burns and Scalds Treatment Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Burns and Scalds Treatment Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 MEBO
11.1.1 MEBO Corporation Information
11.1.2 MEBO Business Overview
11.1.3 MEBO Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.1.4 MEBO Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 MEBO Burns and Scalds Treatment Sales by Product in 2025
11.1.6 MEBO Burns and Scalds Treatment Sales by Application in 2025
11.1.7 MEBO Burns and Scalds Treatment Sales by Geographic Area in 2025
11.1.8 MEBO Burns and Scalds Treatment SWOT Analysis
11.1.9 MEBO Recent Developments
11.2 B. Braun
11.2.1 B. Braun Corporation Information
11.2.2 B. Braun Business Overview
11.2.3 B. Braun Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.2.4 B. Braun Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 B. Braun Burns and Scalds Treatment Sales by Product in 2025
11.2.6 B. Braun Burns and Scalds Treatment Sales by Application in 2025
11.2.7 B. Braun Burns and Scalds Treatment Sales by Geographic Area in 2025
11.2.8 B. Braun Burns and Scalds Treatment SWOT Analysis
11.2.9 B. Braun Recent Developments
11.3 Integra LifeSciences
11.3.1 Integra LifeSciences Corporation Information
11.3.2 Integra LifeSciences Business Overview
11.3.3 Integra LifeSciences Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.3.4 Integra LifeSciences Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Integra LifeSciences Burns and Scalds Treatment Sales by Product in 2025
11.3.6 Integra LifeSciences Burns and Scalds Treatment Sales by Application in 2025
11.3.7 Integra LifeSciences Burns and Scalds Treatment Sales by Geographic Area in 2025
11.3.8 Integra LifeSciences Burns and Scalds Treatment SWOT Analysis
11.3.9 Integra LifeSciences Recent Developments
11.4 Tianjin Pharmaceutical Da Ren Tang Group Corporation
11.4.1 Tianjin Pharmaceutical Da Ren Tang Group Corporation Corporation Information
11.4.2 Tianjin Pharmaceutical Da Ren Tang Group Corporation Business Overview
11.4.3 Tianjin Pharmaceutical Da Ren Tang Group Corporation Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.4.4 Tianjin Pharmaceutical Da Ren Tang Group Corporation Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Tianjin Pharmaceutical Da Ren Tang Group Corporation Burns and Scalds Treatment Sales by Product in 2025
11.4.6 Tianjin Pharmaceutical Da Ren Tang Group Corporation Burns and Scalds Treatment Sales by Application in 2025
11.4.7 Tianjin Pharmaceutical Da Ren Tang Group Corporation Burns and Scalds Treatment Sales by Geographic Area in 2025
11.4.8 Tianjin Pharmaceutical Da Ren Tang Group Corporation Burns and Scalds Treatment SWOT Analysis
11.4.9 Tianjin Pharmaceutical Da Ren Tang Group Corporation Recent Developments
11.5 Smith & Nephew
11.5.1 Smith & Nephew Corporation Information
11.5.2 Smith & Nephew Business Overview
11.5.3 Smith & Nephew Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.5.4 Smith & Nephew Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Smith & Nephew Burns and Scalds Treatment Sales by Product in 2025
11.5.6 Smith & Nephew Burns and Scalds Treatment Sales by Application in 2025
11.5.7 Smith & Nephew Burns and Scalds Treatment Sales by Geographic Area in 2025
11.5.8 Smith & Nephew Burns and Scalds Treatment SWOT Analysis
11.5.9 Smith & Nephew Recent Developments
11.6 Yangtze River Pharmaceutical
11.6.1 Yangtze River Pharmaceutical Corporation Information
11.6.2 Yangtze River Pharmaceutical Business Overview
11.6.3 Yangtze River Pharmaceutical Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.6.4 Yangtze River Pharmaceutical Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Yangtze River Pharmaceutical Recent Developments
11.7 STADA Thornton & Ross
11.7.1 STADA Thornton & Ross Corporation Information
11.7.2 STADA Thornton & Ross Business Overview
11.7.3 STADA Thornton & Ross Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.7.4 STADA Thornton & Ross Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 STADA Thornton & Ross Recent Developments
11.8 Kenvue Brands LLC
11.8.1 Kenvue Brands LLC Corporation Information
11.8.2 Kenvue Brands LLC Business Overview
11.8.3 Kenvue Brands LLC Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.8.4 Kenvue Brands LLC Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Kenvue Brands LLC Recent Developments
11.9 Changchun OVERSEAS
11.9.1 Changchun OVERSEAS Corporation Information
11.9.2 Changchun OVERSEAS Business Overview
11.9.3 Changchun OVERSEAS Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.9.4 Changchun OVERSEAS Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Changchun OVERSEAS Recent Developments
11.10 Orkla Health
11.10.1 Orkla Health Corporation Information
11.10.2 Orkla Health Business Overview
11.10.3 Orkla Health Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.10.4 Orkla Health Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Orkla Health Recent Developments
11.11 Guangdong Hengjian Investment
11.11.1 Guangdong Hengjian Investment Corporation Information
11.11.2 Guangdong Hengjian Investment Business Overview
11.11.3 Guangdong Hengjian Investment Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.11.4 Guangdong Hengjian Investment Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Guangdong Hengjian Investment Recent Developments
11.12 Otsuka Pharmaceutical Co
11.12.1 Otsuka Pharmaceutical Co Corporation Information
11.12.2 Otsuka Pharmaceutical Co Business Overview
11.12.3 Otsuka Pharmaceutical Co Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.12.4 Otsuka Pharmaceutical Co Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Otsuka Pharmaceutical Co Recent Developments
11.13 Tonghua Maoxiang Medical Co
11.13.1 Tonghua Maoxiang Medical Co Corporation Information
11.13.2 Tonghua Maoxiang Medical Co Business Overview
11.13.3 Tonghua Maoxiang Medical Co Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.13.4 Tonghua Maoxiang Medical Co Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Tonghua Maoxiang Medical Co Recent Developments
11.14 Cipla
11.14.1 Cipla Corporation Information
11.14.2 Cipla Business Overview
11.14.3 Cipla Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.14.4 Cipla Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Cipla Recent Developments
11.15 Mitsubishi Tanabe Pharma Corporation
11.15.1 Mitsubishi Tanabe Pharma Corporation Corporation Information
11.15.2 Mitsubishi Tanabe Pharma Corporation Business Overview
11.15.3 Mitsubishi Tanabe Pharma Corporation Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.15.4 Mitsubishi Tanabe Pharma Corporation Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
11.16 Chongqing GankyilL Bio-Technology
11.16.1 Chongqing GankyilL Bio-Technology Corporation Information
11.16.2 Chongqing GankyilL Bio-Technology Business Overview
11.16.3 Chongqing GankyilL Bio-Technology Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.16.4 Chongqing GankyilL Bio-Technology Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Chongqing GankyilL Bio-Technology Recent Developments
11.17 Quest Products, LLC
11.17.1 Quest Products, LLC Corporation Information
11.17.2 Quest Products, LLC Business Overview
11.17.3 Quest Products, LLC Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.17.4 Quest Products, LLC Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Quest Products, LLC Recent Developments
11.18 Jianmin Pharmaceutical Group Co
11.18.1 Jianmin Pharmaceutical Group Co Corporation Information
11.18.2 Jianmin Pharmaceutical Group Co Business Overview
11.18.3 Jianmin Pharmaceutical Group Co Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.18.4 Jianmin Pharmaceutical Group Co Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Jianmin Pharmaceutical Group Co Recent Developments
11.19 Acme United Corp.
11.19.1 Acme United Corp. Corporation Information
11.19.2 Acme United Corp. Business Overview
11.19.3 Acme United Corp. Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.19.4 Acme United Corp. Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Acme United Corp. Recent Developments
11.20 Dongwha Pharm
11.20.1 Dongwha Pharm Corporation Information
11.20.2 Dongwha Pharm Business Overview
11.20.3 Dongwha Pharm Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.20.4 Dongwha Pharm Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 Dongwha Pharm Recent Developments
11.21 CR Pharmaceutical Commercial Group Co
11.21.1 CR Pharmaceutical Commercial Group Co Corporation Information
11.21.2 CR Pharmaceutical Commercial Group Co Business Overview
11.21.3 CR Pharmaceutical Commercial Group Co Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.21.4 CR Pharmaceutical Commercial Group Co Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 CR Pharmaceutical Commercial Group Co Recent Developments
11.22 Safetec Of America
11.22.1 Safetec Of America Corporation Information
11.22.2 Safetec Of America Business Overview
11.22.3 Safetec Of America Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.22.4 Safetec Of America Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 Safetec Of America Recent Developments
11.23 Chongqing Taiji Industry
11.23.1 Chongqing Taiji Industry Corporation Information
11.23.2 Chongqing Taiji Industry Business Overview
11.23.3 Chongqing Taiji Industry Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.23.4 Chongqing Taiji Industry Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.23.5 Chongqing Taiji Industry Recent Developments
11.24 North China Pharmaceutical Co
11.24.1 North China Pharmaceutical Co Corporation Information
11.24.2 North China Pharmaceutical Co Business Overview
11.24.3 North China Pharmaceutical Co Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.24.4 North China Pharmaceutical Co Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.24.5 North China Pharmaceutical Co Recent Developments
11.25 Xiangxi Hongcheng
11.25.1 Xiangxi Hongcheng Corporation Information
11.25.2 Xiangxi Hongcheng Business Overview
11.25.3 Xiangxi Hongcheng Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.25.4 Xiangxi Hongcheng Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.25.5 Xiangxi Hongcheng Recent Developments
11.26 Aoxing Pharmaceutical
11.26.1 Aoxing Pharmaceutical Corporation Information
11.26.2 Aoxing Pharmaceutical Business Overview
11.26.3 Aoxing Pharmaceutical Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.26.4 Aoxing Pharmaceutical Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.26.5 Aoxing Pharmaceutical Recent Developments
11.27 Jilin Aodong Pharmaceutical Group Co
11.27.1 Jilin Aodong Pharmaceutical Group Co Corporation Information
11.27.2 Jilin Aodong Pharmaceutical Group Co Business Overview
11.27.3 Jilin Aodong Pharmaceutical Group Co Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.27.4 Jilin Aodong Pharmaceutical Group Co Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.27.5 Jilin Aodong Pharmaceutical Group Co Recent Developments
11.28 Beijing Tong Ren Tang Chinese Medicine Co
11.28.1 Beijing Tong Ren Tang Chinese Medicine Co Corporation Information
11.28.2 Beijing Tong Ren Tang Chinese Medicine Co Business Overview
11.28.3 Beijing Tong Ren Tang Chinese Medicine Co Burns and Scalds Treatment Product Models, Descriptions and Specifications
11.28.4 Beijing Tong Ren Tang Chinese Medicine Co Burns and Scalds Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
11.28.5 Beijing Tong Ren Tang Chinese Medicine Co Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Burns and Scalds Treatment Industry Chain
12.2 Burns and Scalds Treatment Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Burns and Scalds Treatment Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Burns and Scalds Treatment Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Burns and Scalds Treatment Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Burns and Scalds Treatment Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Burns and Scalds Treatment Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Burns and Scalds Treatment Market Size Growth Rate by Treatment Product Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Burns and Scalds Treatment Market Size Growth Rate by Burn Depth, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Burns and Scalds Treatment Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Burns and Scalds Treatment Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Burns and Scalds Treatment Revenue by Region (US$ Million), 2021-2026
Table 7. Global Burns and Scalds Treatment Revenue by Region (US$ Million), 2027-2032
Table 8. Global Burns and Scalds Treatment Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Burns and Scalds Treatment Sales by Region (K Units), 2021-2026
Table 10. Global Burns and Scalds Treatment Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Burns and Scalds Treatment Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Burns and Scalds Treatment Sales Share by Manufacturers (2021-2026)
Table 14. Global Burns and Scalds Treatment Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Burns and Scalds Treatment Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Burns and Scalds Treatment Revenue, 2025
Table 18. Global Burns and Scalds Treatment Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Burns and Scalds Treatment Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 20. Key Manufacturers Burns and Scalds Treatment Manufacturing Base and Headquarters
Table 21. Global Burns and Scalds Treatment Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Burns and Scalds Treatment Sales Volume by Type (K Units), 2021-2026
Table 25. Global Burns and Scalds Treatment Sales Volume by Type (K Units), 2027-2032
Table 26. Global Burns and Scalds Treatment Revenue by Type (US$ Million), 2021-2026
Table 27. Global Burns and Scalds Treatment Revenue by Type (US$ Million), 2027-2032
Table 28. Global Burns and Scalds Treatment Sales Volume by Treatment Product Type (K Units), 2021-2026
Table 29. Global Burns and Scalds Treatment Sales Volume by Treatment Product Type (K Units), 2027-2032
Table 30. Global Burns and Scalds Treatment Revenue by Treatment Product Type (US$ Million), 2021-2026
Table 31. Global Burns and Scalds Treatment Revenue by Treatment Product Type (US$ Million), 2027-2032
Table 32. Global Burns and Scalds Treatment Sales Volume by Burn Depth (K Units), 2021-2026
Table 33. Global Burns and Scalds Treatment Sales Volume by Burn Depth (K Units), 2027-2032
Table 34. Global Burns and Scalds Treatment Revenue by Burn Depth (US$ Million), 2021-2026
Table 35. Global Burns and Scalds Treatment Revenue by Burn Depth (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Burns and Scalds Treatment Sales by Application (K Units), 2021-2026
Table 38. Global Burns and Scalds Treatment Sales by Application (K Units), 2027-2032
Table 39. Burns and Scalds Treatment High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Burns and Scalds Treatment Revenue by Application (US$ Million), 2021-2026
Table 41. Global Burns and Scalds Treatment Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Burns and Scalds Treatment Growth Accelerators and Market Barriers
Table 45. North America Burns and Scalds Treatment Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Burns and Scalds Treatment Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Burns and Scalds Treatment Growth Accelerators and Market Barriers
Table 48. Europe Burns and Scalds Treatment Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Burns and Scalds Treatment Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Burns and Scalds Treatment Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Burns and Scalds Treatment Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Burns and Scalds Treatment Growth Accelerators and Market Barriers
Table 53. Southeast Asia Burns and Scalds Treatment Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Burns and Scalds Treatment Investment Opportunities and Key Challenges
Table 55. Central and South America Burns and Scalds Treatment Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Burns and Scalds Treatment Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Burns and Scalds Treatment Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. MEBO Corporation Information
Table 59. MEBO Description and Major Businesses
Table 60. MEBO Product Models, Descriptions and Specifications
Table 61. MEBO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 62. MEBO Sales Value Proportion by Product in 2025
Table 63. MEBO Sales Value Proportion by Application in 2025
Table 64. MEBO Sales Value Proportion by Geographic Area in 2025
Table 65. MEBO Burns and Scalds Treatment SWOT Analysis
Table 66. MEBO Recent Developments
Table 67. B. Braun Corporation Information
Table 68. B. Braun Description and Major Businesses
Table 69. B. Braun Product Models, Descriptions and Specifications
Table 70. B. Braun Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. B. Braun Sales Value Proportion by Product in 2025
Table 72. B. Braun Sales Value Proportion by Application in 2025
Table 73. B. Braun Sales Value Proportion by Geographic Area in 2025
Table 74. B. Braun Burns and Scalds Treatment SWOT Analysis
Table 75. B. Braun Recent Developments
Table 76. Integra LifeSciences Corporation Information
Table 77. Integra LifeSciences Description and Major Businesses
Table 78. Integra LifeSciences Product Models, Descriptions and Specifications
Table 79. Integra LifeSciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Integra LifeSciences Sales Value Proportion by Product in 2025
Table 81. Integra LifeSciences Sales Value Proportion by Application in 2025
Table 82. Integra LifeSciences Sales Value Proportion by Geographic Area in 2025
Table 83. Integra LifeSciences Burns and Scalds Treatment SWOT Analysis
Table 84. Integra LifeSciences Recent Developments
Table 85. Tianjin Pharmaceutical Da Ren Tang Group Corporation Corporation Information
Table 86. Tianjin Pharmaceutical Da Ren Tang Group Corporation Description and Major Businesses
Table 87. Tianjin Pharmaceutical Da Ren Tang Group Corporation Product Models, Descriptions and Specifications
Table 88. Tianjin Pharmaceutical Da Ren Tang Group Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Tianjin Pharmaceutical Da Ren Tang Group Corporation Sales Value Proportion by Product in 2025
Table 90. Tianjin Pharmaceutical Da Ren Tang Group Corporation Sales Value Proportion by Application in 2025
Table 91. Tianjin Pharmaceutical Da Ren Tang Group Corporation Sales Value Proportion by Geographic Area in 2025
Table 92. Tianjin Pharmaceutical Da Ren Tang Group Corporation Burns and Scalds Treatment SWOT Analysis
Table 93. Tianjin Pharmaceutical Da Ren Tang Group Corporation Recent Developments
Table 94. Smith & Nephew Corporation Information
Table 95. Smith & Nephew Description and Major Businesses
Table 96. Smith & Nephew Product Models, Descriptions and Specifications
Table 97. Smith & Nephew Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Smith & Nephew Sales Value Proportion by Product in 2025
Table 99. Smith & Nephew Sales Value Proportion by Application in 2025
Table 100. Smith & Nephew Sales Value Proportion by Geographic Area in 2025
Table 101. Smith & Nephew Burns and Scalds Treatment SWOT Analysis
Table 102. Smith & Nephew Recent Developments
Table 103. Yangtze River Pharmaceutical Corporation Information
Table 104. Yangtze River Pharmaceutical Description and Major Businesses
Table 105. Yangtze River Pharmaceutical Product Models, Descriptions and Specifications
Table 106. Yangtze River Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Yangtze River Pharmaceutical Recent Developments
Table 108. STADA Thornton & Ross Corporation Information
Table 109. STADA Thornton & Ross Description and Major Businesses
Table 110. STADA Thornton & Ross Product Models, Descriptions and Specifications
Table 111. STADA Thornton & Ross Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. STADA Thornton & Ross Recent Developments
Table 113. Kenvue Brands LLC Corporation Information
Table 114. Kenvue Brands LLC Description and Major Businesses
Table 115. Kenvue Brands LLC Product Models, Descriptions and Specifications
Table 116. Kenvue Brands LLC Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Kenvue Brands LLC Recent Developments
Table 118. Changchun OVERSEAS Corporation Information
Table 119. Changchun OVERSEAS Description and Major Businesses
Table 120. Changchun OVERSEAS Product Models, Descriptions and Specifications
Table 121. Changchun OVERSEAS Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Changchun OVERSEAS Recent Developments
Table 123. Orkla Health Corporation Information
Table 124. Orkla Health Description and Major Businesses
Table 125. Orkla Health Product Models, Descriptions and Specifications
Table 126. Orkla Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Orkla Health Recent Developments
Table 128. Guangdong Hengjian Investment Corporation Information
Table 129. Guangdong Hengjian Investment Description and Major Businesses
Table 130. Guangdong Hengjian Investment Product Models, Descriptions and Specifications
Table 131. Guangdong Hengjian Investment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Guangdong Hengjian Investment Recent Developments
Table 133. Otsuka Pharmaceutical Co Corporation Information
Table 134. Otsuka Pharmaceutical Co Description and Major Businesses
Table 135. Otsuka Pharmaceutical Co Product Models, Descriptions and Specifications
Table 136. Otsuka Pharmaceutical Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Otsuka Pharmaceutical Co Recent Developments
Table 138. Tonghua Maoxiang Medical Co Corporation Information
Table 139. Tonghua Maoxiang Medical Co Description and Major Businesses
Table 140. Tonghua Maoxiang Medical Co Product Models, Descriptions and Specifications
Table 141. Tonghua Maoxiang Medical Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Tonghua Maoxiang Medical Co Recent Developments
Table 143. Cipla Corporation Information
Table 144. Cipla Description and Major Businesses
Table 145. Cipla Product Models, Descriptions and Specifications
Table 146. Cipla Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Cipla Recent Developments
Table 148. Mitsubishi Tanabe Pharma Corporation Corporation Information
Table 149. Mitsubishi Tanabe Pharma Corporation Description and Major Businesses
Table 150. Mitsubishi Tanabe Pharma Corporation Product Models, Descriptions and Specifications
Table 151. Mitsubishi Tanabe Pharma Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Mitsubishi Tanabe Pharma Corporation Recent Developments
Table 153. Chongqing GankyilL Bio-Technology Corporation Information
Table 154. Chongqing GankyilL Bio-Technology Description and Major Businesses
Table 155. Chongqing GankyilL Bio-Technology Product Models, Descriptions and Specifications
Table 156. Chongqing GankyilL Bio-Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Chongqing GankyilL Bio-Technology Recent Developments
Table 158. Quest Products, LLC Corporation Information
Table 159. Quest Products, LLC Description and Major Businesses
Table 160. Quest Products, LLC Product Models, Descriptions and Specifications
Table 161. Quest Products, LLC Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Quest Products, LLC Recent Developments
Table 163. Jianmin Pharmaceutical Group Co Corporation Information
Table 164. Jianmin Pharmaceutical Group Co Description and Major Businesses
Table 165. Jianmin Pharmaceutical Group Co Product Models, Descriptions and Specifications
Table 166. Jianmin Pharmaceutical Group Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Jianmin Pharmaceutical Group Co Recent Developments
Table 168. Acme United Corp. Corporation Information
Table 169. Acme United Corp. Description and Major Businesses
Table 170. Acme United Corp. Product Models, Descriptions and Specifications
Table 171. Acme United Corp. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Acme United Corp. Recent Developments
Table 173. Dongwha Pharm Corporation Information
Table 174. Dongwha Pharm Description and Major Businesses
Table 175. Dongwha Pharm Product Models, Descriptions and Specifications
Table 176. Dongwha Pharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Dongwha Pharm Recent Developments
Table 178. CR Pharmaceutical Commercial Group Co Corporation Information
Table 179. CR Pharmaceutical Commercial Group Co Description and Major Businesses
Table 180. CR Pharmaceutical Commercial Group Co Product Models, Descriptions and Specifications
Table 181. CR Pharmaceutical Commercial Group Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. CR Pharmaceutical Commercial Group Co Recent Developments
Table 183. Safetec Of America Corporation Information
Table 184. Safetec Of America Description and Major Businesses
Table 185. Safetec Of America Product Models, Descriptions and Specifications
Table 186. Safetec Of America Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. Safetec Of America Recent Developments
Table 188. Chongqing Taiji Industry Corporation Information
Table 189. Chongqing Taiji Industry Description and Major Businesses
Table 190. Chongqing Taiji Industry Product Models, Descriptions and Specifications
Table 191. Chongqing Taiji Industry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. Chongqing Taiji Industry Recent Developments
Table 193. North China Pharmaceutical Co Corporation Information
Table 194. North China Pharmaceutical Co Description and Major Businesses
Table 195. North China Pharmaceutical Co Product Models, Descriptions and Specifications
Table 196. North China Pharmaceutical Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 197. North China Pharmaceutical Co Recent Developments
Table 198. Xiangxi Hongcheng Corporation Information
Table 199. Xiangxi Hongcheng Description and Major Businesses
Table 200. Xiangxi Hongcheng Product Models, Descriptions and Specifications
Table 201. Xiangxi Hongcheng Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 202. Xiangxi Hongcheng Recent Developments
Table 203. Aoxing Pharmaceutical Corporation Information
Table 204. Aoxing Pharmaceutical Description and Major Businesses
Table 205. Aoxing Pharmaceutical Product Models, Descriptions and Specifications
Table 206. Aoxing Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 207. Aoxing Pharmaceutical Recent Developments
Table 208. Jilin Aodong Pharmaceutical Group Co Corporation Information
Table 209. Jilin Aodong Pharmaceutical Group Co Description and Major Businesses
Table 210. Jilin Aodong Pharmaceutical Group Co Product Models, Descriptions and Specifications
Table 211. Jilin Aodong Pharmaceutical Group Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 212. Jilin Aodong Pharmaceutical Group Co Recent Developments
Table 213. Beijing Tong Ren Tang Chinese Medicine Co Corporation Information
Table 214. Beijing Tong Ren Tang Chinese Medicine Co Description and Major Businesses
Table 215. Beijing Tong Ren Tang Chinese Medicine Co Product Models, Descriptions and Specifications
Table 216. Beijing Tong Ren Tang Chinese Medicine Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 217. Beijing Tong Ren Tang Chinese Medicine Co Recent Developments
Table 218. Key Raw Materials Distribution
Table 219. Raw Materials Key Suppliers
Table 220. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 221. Milestones in Production Technology Evolution
Table 222. Distributors List
Table 223. Market Trends and Market Evolution
Table 224. Market Drivers and Opportunities
Table 225. Market Challenges, Risks, and Restraints
Table 226. Research Programs/Design for This Report
Table 227. Key Data Information from Secondary Sources
Table 228. Key Data Information from Primary Sources

List of Figures
Figure 1. Burns and Scalds Treatment Product Picture
Figure 2. Global Burns and Scalds Treatment Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Salve Product Picture
Figure 4. Spray Product Picture
Figure 5. Oil Product Picture
Figure 6. Other Product Picture
Figure 7. Global Burns and Scalds Treatment Market Size Growth Rate by Treatment Product Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 8. Burn Ointments and Creams Product Picture
Figure 9. Burn Dressings Product Picture
Figure 10. Burn Sprays and Gels Product Picture
Figure 11. Others Product Picture
Figure 12. Global Burns and Scalds Treatment Market Size Growth Rate by Burn Depth, 2021 vs 2025 vs 2032 (US$ Million)
Figure 13. Superficial Burns (First-degree) Product Picture
Figure 14. Superficial Partial-thickness Burns (Superficial Second-degree) Product Picture
Figure 15. Deep Partial-thickness Burns (Deep Second-degree) Product Picture
Figure 16. Full-thickness Burns (Third-degree) Product Picture
Figure 17. Global Burns and Scalds Treatment Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 18. Hospitals and Clinics
Figure 19. Retail Pharmacies
Figure 20. E-commerce Platforms
Figure 21. Other
Figure 22. Burns and Scalds Treatment Report Years Considered
Figure 23. Global Burns and Scalds Treatment Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 25. Global Burns and Scalds Treatment Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 26. Global Burns and Scalds Treatment Revenue-Based Market Share by Region (2021-2032)
Figure 27. Global Burns and Scalds Treatment Sales (K Units), 2021-2032
Figure 28. Global Burns and Scalds Treatment Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 29. Global Burns and Scalds Treatment Sales Market Share by Region (2021-2032)
Figure 30. Top 5 and Top 10 Manufacturers Burns and Scalds Treatment Sales Volume Market Share in 2025
Figure 31. Global Burns and Scalds Treatment Revenue-Based Market Share Ranking (2025)
Figure 32. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 33. Salve Revenue-Based Market Share by Manufacturer in 2025
Figure 34. Spray Revenue-Based Market Share by Manufacturer in 2025
Figure 35. Oil Revenue-Based Market Share by Manufacturer in 2025
Figure 36. Other Revenue-Based Market Share by Manufacturer in 2025
Figure 37. Global Burns and Scalds Treatment Sales Volume-Based Market Share by Type (2021-2032)
Figure 38. Global Burns and Scalds Treatment Revenue-Based Market Share by Type (2021-2032)
Figure 39. Global Burns and Scalds Treatment ASP by Type (US$/Unit), 2021-2032
Figure 40. Global Burns and Scalds Treatment Sales Volume-Based Market Share by Treatment Product Type (2021-2032)
Figure 41. Global Burns and Scalds Treatment Revenue-Based Market Share by Treatment Product Type (2021-2032)
Figure 42. Global Burns and Scalds Treatment ASP by Treatment Product Type (US$/Unit), 2021-2032
Figure 43. Global Burns and Scalds Treatment Sales Volume-Based Market Share by Burn Depth (2021-2032)
Figure 44. Global Burns and Scalds Treatment Revenue-Based Market Share by Burn Depth (2021-2032)
Figure 45. Global Burns and Scalds Treatment ASP by Burn Depth (US$/Unit), 2021-2032
Figure 46. Global Burns and Scalds Treatment Sales Market Share by Application (2021-2032)
Figure 47. Global Burns and Scalds Treatment Revenue-Based Market Share by Application (2021-2032)
Figure 48. Global Burns and Scalds Treatment ASP by Application (US$/Unit), 2021-2032
Figure 49. North America Burns and Scalds Treatment Sales YoY (K Units), 2021-2032
Figure 50. North America Burns and Scalds Treatment Revenue YoY (US$ Million), 2021-2032
Figure 51. North America Top 5 Manufacturers Burns and Scalds Treatment Sales Revenue (US$ Million) in 2025
Figure 52. North America Burns and Scalds Treatment Sales Volume (K Units) by Application (2021-2032)
Figure 53. North America Burns and Scalds Treatment Sales Revenue (US$ Million) by Application (2021-2032)
Figure 54. US Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 55. Canada Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 56. Mexico Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 57. Europe Burns and Scalds Treatment Sales YoY (K Units), 2021-2032
Figure 58. Europe Burns and Scalds Treatment Revenue YoY (US$ Million), 2021-2032
Figure 59. Europe Top 5 Manufacturers Burns and Scalds Treatment Sales Revenue (US$ Million) in 2025
Figure 60. Europe Burns and Scalds Treatment Sales Volume (K Units) by Application (2021-2032)
Figure 61. Europe Burns and Scalds Treatment Sales Revenue (US$ Million) by Application (2021-2032)
Figure 62. Germany Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 63. France Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 64. U.K. Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 65. Italy Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 66. Russia Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 67. Asia-Pacific Burns and Scalds Treatment Sales YoY (K Units), 2021-2032
Figure 68. Asia-Pacific Burns and Scalds Treatment Revenue YoY (US$ Million), 2021-2032
Figure 69. Asia-Pacific Top 8 Manufacturers Burns and Scalds Treatment Sales Revenue (US$ Million) in 2025
Figure 70. Asia-Pacific Burns and Scalds Treatment Sales Volume (K Units) by Application (2021-2032)
Figure 71. Asia-Pacific Burns and Scalds Treatment Sales Revenue (US$ Million) by Application (2021-2032)
Figure 72. Indonesia Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 73. Japan Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 74. South Korea Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 75. China Taiwan Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 76. India Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 77. Central and South America Burns and Scalds Treatment Sales YoY (K Units), 2021-2032
Figure 78. Central and South America Burns and Scalds Treatment Revenue YoY (US$ Million), 2021-2032
Figure 79. Central and South America Top 5 Manufacturers Burns and Scalds Treatment Sales Revenue (US$ Million) in 2025
Figure 80. Central and South America Burns and Scalds Treatment Sales Volume (K Units) by Application (2021-2032)
Figure 81. Central and South America Burns and Scalds Treatment Sales Revenue (US$ Million) by Application (2021-2032)
Figure 82. Brazil Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 83. Argentina Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 84. Middle East, and Africa Burns and Scalds Treatment Sales YoY (K Units), 2021-2032
Figure 85. Middle East and Africa Burns and Scalds Treatment Revenue YoY (US$ Million), 2021-2032
Figure 86. Middle East and Africa Top 5 Manufacturers Burns and Scalds Treatment Sales Revenue (US$ Million) in 2025
Figure 87. Middle East and Africa Burns and Scalds Treatment Sales Volume (K Units) by Application (2021-2032)
Figure 88. Middle East and Africa Burns and Scalds Treatment Sales Revenue (US$ Million) by Application (2021-2032)
Figure 89. GCC Countries Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 90. Turkey Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 91. Egypt Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 92. South Africa Burns and Scalds Treatment Revenue (US$ Million), 2021-2032
Figure 93. Burns and Scalds Treatment Industry Chain Mapping
Figure 94. Regional Burns and Scalds Treatment Manufacturing Base Distribution (%)
Figure 95. Global Burns and Scalds Treatment Production Market Share by Region (2021-2032)
Figure 96. Burns and Scalds Treatment Production Process
Figure 97. Regional Burns and Scalds Treatment Production Cost Structure
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed